)
)
14th October 2026 | Hilton Airport Hotel | Boston
The Next-Generation ADC Development & Manufacturing Summit is a focused, one-day meeting bringing together industry experts across antibody–drug conjugate (ADC) discovery, development, and manufacturing. The agenda spans the full ADC lifecycle, from target selection and antibody design through to linker chemistry, payload optimization, and scalable manufacturing strategies.
Through a mix of keynote presentations, spotlight sessions, and in-depth roundtable discussions, the event explores key challenges such as improving tumour targeting, enhancing linker stability and payload delivery, and overcoming manufacturing and scalability bottlenecks. Attendees gain practical insights into emerging technologies, best practices, and collaborative approaches shaping the future of ADC therapeutics.
Designed for senior scientists and decision-makers, the summit emphasizes interactive, discussion-led sessions that enable peer-to-peer exchange, problem-solving, and networking across the ADC ecosystem.
Summit Agenda
08:00
-
Head to the registration desk to pick up your name badge and your personalized agenda from one of our friendly team. Feel free to ask us any questions you might have about the day ahead!
08:30
-
ADC market evolution. Key bottlenecks slowing development. Balancing innovation with manufacturability. What next-generation ADC programs require.
09:00
-
Avoiding costly development delays. Early CMC decision-making. Integrating analytical and manufacturing planning. Accelerating IND readiness.
09:30
-
Formulation stability. Aggregation challenges. Excipient selection. Shelf-life optimisation.
-
Process development planning. Analytical package requirements. Development milestones. Comparability strategy.
-
DAR characterisation. Impurity profiling. Potency assays. Release testing strategies.
-
Scaling conjugation processes. Tech transfer challenges. GMP readiness. CDMO outsourcing strategy.
-
IND/CTA expectations. CMC submission requirements. Global regulatory considerations. Inspection readiness.
10:35
-
Dedicated time reserved for your pre-booked 1:1 meetings with our event partners and / or to networking with your senior industry peers.
11:05
-
Dedicated time reserved for your pre-booked 1:1 meetings with our event partners and / or to networking with your senior industry peers.
11:35
-
Grab a refreshing beverage and tasty snack to power you through the next round of expertly curated roundtables, led by our industry partners.
11:45
-
Overcoming ADC formulation stability challenges. Reducing aggregation and degradation risk. Excipient selection strategies for complex ADC molecules. Improving shelf-life, storage stability, and drug …
-
Integrating CMC strategy earlier to accelerate development timelines. Avoiding common CMC bottlenecks that delay IND readiness. Aligning process development, analytical, and manufacturing workflows. B …
-
Analytical approaches for complex ADC characterisation. Improving efficiency in DAR, impurity, and potency analysis. Ensuring product consistency and quality control across development. Aligning analy …
-
Scaling ADC manufacturing from development through GMP production. Overcoming tech transfer and process reproducibility challenges. Evaluating outsourcing vs in-house manufacturing strategies. Improvi …
-
IND / CTA expectations. CMC submission requirements. Quality documentation. Global regulatory considerations.
12:45
-
Retreat to the on-site restaurant, where you will be treated to a delicious lunch menu featuring a selection of dishes freshly prepared for you.
13:50
-
Preparing for late-stage scale-up. Ensuring supply chain readiness. Manufacturing capacity planning. Commercial manufacturing considerations.
14:25
-
Dedicated time reserved for your pre-booked 1:1 meetings with our event partners and / or to networking with your senior industry peers.
14:55
-
Dedicated time reserved for your pre-booked 1:1 meetings with our event partners and / or to networking with your senior industry peers.
15:25
-
Grab a quick beverage and delicious snack to power you through the exciting afternoon sessions. Don't forget to network and make a new connection.
15:35
-
Managing off-target toxicity. Improving therapeutic window. Dose optimisation strategies. Reducing development risk.
16:05
-
Overcoming complex formulation barriers. Improving long-term stability. Enabling scalable drug product development.
-
Improving development efficiency. Reducing programme delays. Smarter development workflows.
-
Analytical control frameworks. Ensuring batch consistency. Quality risk mitigation.
-
Scaling manufacturing operations. CDMO partnership models. Reproducibility challenges.
-
Inspection readiness. Quality oversight. Regulatory risk mitigation. Global compliance expectations.
17:10
-
Next-generation ADC execution models. Manufacturing innovation. Regulatory evolution. Accelerating clinical success.
17:45
-
Relax at the end of a highly productive day, grab a cool, refreshing beverage and a delicious snack, and catch up with colleagues and newly formed connections to reflect on the day.
){kind=logo}
Location
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)